Cargando…

Careful clinical evaluation of donor fraction cell-free DNA in rejection surveillance after heart transplantation

Detalles Bibliográficos
Autores principales:	Napoli, Claudio, Maiello, Ciro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society for Heart and Lung Transplantation. 2020
Materias:	Case Anecdote, Comments and Opinions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305867/ https://www.ncbi.nlm.nih.gov/pubmed/32660780 http://dx.doi.org/10.1016/j.healun.2020.06.004

Ejemplares similares

Kinetics of cellular and humoral responses to third COVID-19 vaccine in heart transplant recipients: Correspondence
por: Sokaromdee, Pathum, et al.
Publicado: (2022)

First lung and kidney multi-organ transplant following COVID-19 Infection
por: Guenthart, Brandon A., et al.
Publicado: (2021)

Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection
por: Weber, Sven C., et al.
Publicado: (2022)

Successful lung transplantation in COVID-19 PCR positive patients: A single-center experience
por: Natori, Yoichiro, et al.
Publicado: (2023)

Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021)

Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19
por: Mejia, Erika J., et al.
Publicado: (2022)

In Situ Immune Profiling Identifies Immune Players Involved in Allograft Rejection: A Call for Precision Medicine
por: Napoli, Claudio, et al.
Publicado: (2020)

Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation
por: Keller, Michael, et al.
Publicado: (2021)

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
por: Kim, Paul J., et al.
Publicado: (2022)

Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
por: Mantios, Evangelos, et al.
Publicado: (2023)

Early Experience Using Donor-derived Cell-free DNA for Surveillance of Rejection Following Simultaneous Pancreas and Kidney Transplantation
por: Williams, Michael D., et al.
Publicado: (2022)

Veno-arterial Extracorporeal Membrane Oxygenation as Bridge to Heart Transplantation: The Way Forward
por: Montisci, Andrea, et al.
Publicado: (2021)

Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection
por: Afzal, Aasim, et al.
Publicado: (2021)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Donor-Derived Cell-Free DNA (ddcf-DNA) and Acute Antibody-Mediated Rejection in Kidney Transplantation
por: Jaikaransingh, Vishal, et al.
Publicado: (2021)

Doing it right: Caring for and protecting patient information for US organ donors and transplant recipients
por: Perakslis, Eric D., et al.
Publicado: (2023)

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
por: Hurkmans, Daan P., et al.
Publicado: (2019)

Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
por: Li, Yunhui, et al.
Publicado: (2023)

Inference of natural selection from ancient DNA
por: Dehasque, Marianne, et al.
Publicado: (2020)

Comment on Oehler et al. Outcome and Midterm Survival after Heart Transplantation Is Independent from Donor Length of Stay in the Intensive Care Unit. Life 2022, 12, 1053
por: Thet, Myat Soe, et al.
Publicado: (2023)

Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA
por: Mehta, Shikha G., et al.
Publicado: (2018)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts
por: Fernando, Edwin, et al.
Publicado: (2023)

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study
por: Zhang, Huanxi, et al.
Publicado: (2020)

Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023)

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Inactivation of DNA repair—prospects for boosting cancer immune surveillance
por: Truini, Anna, et al.
Publicado: (2018)

Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability
por: North, Paula E., et al.
Publicado: (2020)

Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients
por: Zhao, Dong, et al.
Publicado: (2021)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
por: Martuszewski, Adrian, et al.
Publicado: (2021)

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation
por: Tanaka, Shin, et al.
Publicado: (2018)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Novel insights in the clinical management of hyperimmune patients before and after transplantation
por: Grimaldi, Vincenzo, et al.
Publicado: (2023)

The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation
por: Khush, Kiran K., et al.
Publicado: (2021)

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022)

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation
por: Ventura-Aguiar, Pedro, et al.
Publicado: (2022)

COVID-19 positive donor for solid organ transplantation
por: Peghin, Maddalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4p2b42ddcglklapkkgn0319nc